Division of Internal Medicine, Department of Medicine, Hofstra North Shore-LIJ School of Medicine, Manhasset, New York.
JAMA Intern Med. 2013 Sep 23;173(17):1584-91. doi: 10.1001/jamainternmed.2013.8980.
There is consensus that incorporating clinical decision support into electronic health records will improve quality of care, contain costs, and reduce overtreatment, but this potential has yet to be demonstrated in clinical trials.
To assess the influence of a customized evidence-based clinical decision support tool on the management of respiratory tract infections and on the effectiveness of integrating evidence at the point of care.
DESIGN, SETTING, AND PARTICIPANTS: In a randomized clinical trial, we implemented 2 well-validated integrated clinical prediction rules, namely, the Walsh rule for streptococcal pharyngitis and the Heckerling rule for pneumonia. INTERVENTIONS AND MAIN OUTCOMES AND MEASURES: The intervention group had access to the integrated clinical prediction rule tool and chose whether to complete risk score calculators, order medications, and generate progress notes to assist with complex decision making at the point of care.
The intervention group completed the integrated clinical prediction rule tool in 57.5% of visits. Providers in the intervention group were significantly less likely to order antibiotics than the control group (age-adjusted relative risk, 0.74; 95% CI, 0.60-0.92). The absolute risk of the intervention was 9.2%, and the number needed to treat was 10.8. The intervention group was significantly less likely to order rapid streptococcal tests compared with the control group (relative risk, 0.75; 95% CI, 0.58-0.97; P= .03).
The integrated clinical prediction rule process for integrating complex evidence-based clinical decision report tools is of relevant importance for national initiatives, such as Meaningful Use. TRIAL REGISTRATION clinicaltrials.gov Identifier: NCT01386047.
将临床决策支持纳入电子健康记录将提高医疗质量、控制成本和减少过度治疗,这已达成共识,但这一潜在效果尚未在临床试验中得到证明。
评估定制的基于证据的临床决策支持工具对呼吸道感染管理的影响,以及在护理点整合证据的效果。
设计、设置和参与者:在一项随机临床试验中,我们实施了 2 种经过充分验证的综合临床预测规则,即沃尔什(Walsh)链球菌性咽炎规则和赫克勒(Heckerling)肺炎规则。
干预组可使用综合临床预测规则工具,并选择是否完成风险评分计算器、开处方和生成进度记录,以协助护理点的复杂决策。
干预组在 57.5%的就诊中完成了综合临床预测规则工具。与对照组相比,干预组的医生开抗生素的可能性明显较低(年龄调整后的相对风险,0.74;95%CI,0.60-0.92)。干预的绝对风险为 9.2%,需要治疗的人数为 10.8。与对照组相比,干预组开快速链球菌检测的可能性明显较低(相对风险,0.75;95%CI,0.58-0.97;P=0.03)。
整合复杂基于证据的临床决策报告工具的综合临床预测规则流程对于国家倡议(如有意义的使用)具有重要意义。
clinicaltrials.gov 标识符:NCT01386047。